These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 4316621

  • 1. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J, Bönicke R.
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract] [Full Text] [Related]

  • 2. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M, Toyama H, Mizuno S, Tsukamura S.
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A, Mase M, Yamamoto M, Nakamura H.
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract] [Full Text] [Related]

  • 4. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM, Mkrtchian SV, Afanas'eva IuP.
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract] [Full Text] [Related]

  • 5. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H, Yamadori H, Inoue N, Mabuchi H, Ikeda N, Maekawa N.
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract] [Full Text] [Related]

  • 6. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M, Mancini P, Matzeu M.
    Ann Ist Carlo Forlanini; 1968 Jul; 28(1):25-41. PubMed ID: 4314838
    [No Abstract] [Full Text] [Related]

  • 7. [Drug resistance in Mycobacteria (author's transl)].
    Yamada T, Masuda K.
    Kekkaku; 1976 Oct; 51(10):399-406. PubMed ID: 64637
    [No Abstract] [Full Text] [Related]

  • 8. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK, Kanes W, Davidson PT, Moulding TS.
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [Abstract] [Full Text] [Related]

  • 9. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M.
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract] [Full Text] [Related]

  • 10. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM, Rudoĭ NM.
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M.
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [Abstract] [Full Text] [Related]

  • 12. [The activity of nicotinic acid hydroxylase and pyrocatechase in chemosensitive mycobacteria and their chemoresistant variants].
    Lippelt CH, Bönicke R.
    Zentralbl Bakteriol Orig; 1968 Sep; 209(1):62-71. PubMed ID: 4317775
    [No Abstract] [Full Text] [Related]

  • 13. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV.
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract] [Full Text] [Related]

  • 14. Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.
    Mizuguchi Y, Suga K, Yamada T.
    Microbiol Immunol; 1979 Oct; 23(7):595-604. PubMed ID: 228161
    [Abstract] [Full Text] [Related]

  • 15. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T, Fukuhara Y.
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract] [Full Text] [Related]

  • 16. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y.
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract] [Full Text] [Related]

  • 17. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T, Mizuguchi Y, Suga K.
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract] [Full Text] [Related]

  • 18. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T, Fukuhara Y.
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract] [Full Text] [Related]

  • 19. A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO STREPTOMYCIN, CYCLOSERINE, VIOMYCIN, AND KANAMYCIN OF TUBERCLE BACILLI FROM 100 PATIENTS NEVER TREATED WITH CYCLOSERINE, VIOMYCIN, OR KANAMYCIN.
    HOK TT, SENG TK.
    Am Rev Respir Dis; 1964 Dec; 90():961-2. PubMed ID: 14233803
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K.
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.